Every executive faces health challenges. The difference for a publicly listed company is that everyone watches how you handle it, and investors immediately start asking whether the organisation can survive without you.
Guzman y Gomez co-CEO Hilton Brett is expected to reduce his day-to-day responsibilities later this year as he undergoes a kidney transplant. In preparation for the transplant, Hilton will be required to undertake certain medical procedures. The company notified the ASX of the news, which is the right thing to do.
The official message is reassuring. Founder and Co-CEO Steven Marks and the senior leadership team will lead operations during Brett's treatment, underscoring leadership continuity and operational stability. Leadership structures are in place to support seamless governance during any periods when Brett is unavailable, aiming to reassure stakeholders about operational stability.
That sounds fine on paper. In practice, it raises some genuine questions about how a co-CEO structure actually works when one half steps back. Brett isn't taking a holiday; he faces a serious medical procedure. The honest answer is nobody knows exactly how long his recovery will take, or how focused he'll be able to be in the months afterward.
Consider the timing. GYG was listed on the Australian Securities Exchange on 20 June 2024. So Marks and Brett have been steering a publicly listed company for less than two years. The ASX listing brought its own demands: quarterly results, analyst calls, shareholder expectations. Currently with 272 sites in its portfolio, the business is planning to open a further 18 by the end of the current fiscal year. The company is executing an ambitious expansion while managing a newly public balance sheet.
This is where Brett's infrastructure expertise matters. Under the co-leadership arrangement, Marks oversees food, marketing, operations and the US, while Brett leads finance, IT, HR, legal, real estate and investor relations. Those aren't minor administrative tasks. Real estate deals, investor relations, IT systems, legal compliance: these are the unglamorous but critical foundations any scaling company depends on. When the person running those functions steps back, there's real operational friction, no matter how competent the deputies are.
The company says it's prepared. GYG's commitment to maintaining consistent strategic oversight and business performance while accommodating the health needs of a key executive is exactly what you'd want to hear. But publicly listed companies are also required to highlight material risks. Losing even partial focus from a co-CEO during a critical growth phase is worth taking seriously.
The bigger question is structural. As Guzman y Gomez scales toward its goal of 1,000 Australian restaurants, the company will face decisions that demand more than one person's attention. A co-CEO structure works when both executives are fully engaged and healthy. It tests everyone when one suddenly isn't.
Brett deserves space to deal with something that matters far more than boardroom politics. His health comes first; everything else is secondary. But for shareholders and investors, the company's response over the next few months will reveal something important: whether the structures that worked for a 272-restaurant chain can actually support the 1,000-restaurant ambitions executives keep promoting. If Marks and the leadership team genuinely keep things steady without Brett's daily involvement, that's a vote of confidence in the company's depth. If operations soften or decisions slow, we'll all have learned something worth knowing about how much of Guzman y Gomez's growth story depends on individual effort rather than institutional strength.